Tag : biopharma

Biology

New Genedata Screener Release Features Advanced Assay Registration and Decision Support for Biopharma R&D

Newsemia
BASEL, Switzerland (PRWEB) May 28, 2020 Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Screener ®...
Latest News

AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells

Newsemia
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today a research collaboration with...
Biology

VetStem Biopharma Shares the Success Story of Jesse Who was Treated with VetStem Cell Therapy

Newsemia
POWAY, Calif. (PRWEB) December 03, 2019 Bold Brahim aka Jesse, a Spanish Arabian, was 11 years old when he suddenly went non-weightbearing lame on his...
Biology

VetStem Biopharma Shares the Success Story of Ole who was Treated with VetStem Cell Therapy by Dr. Holly Mullen

Newsemia
POWAY, Calif. (PRWEB) November 05, 2019 Ole, a German Shepherd, was demonstrating signs of osteoarthritis in April 2019. He was lame and stiff and had...
Biology

East/West CEO Brings Together Global Biopharma Leaders this January to Network, Share Insights on the 2020 Industry Outlook

Newsemia
SAN FRANCISCO (PRWEB) November 06, 2019 LeadingBiotech ,?an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its East/West...
Latest News

Servier acquires non-Hodgkin B-cell lymphoma treatment PIXUVRI® (pixantrone) from CTI BioPharma, strengthening the Servier oncology portfolio

Newsemia
PARIS–(BUSINESS WIRE)–Servier, an independent international pharmaceutical company, today announced the acquisition of PIXUVRI® from CTI BioPharma. PIXUVRI is a treatment for adult patients with multiply...
Biology

VetStem Biopharma Shares the Success Story of Tucker who was Treated with VetStem Cell Therapy by Dr. Glenn Behan

Newsemia
POWAY, Calif. (PRWEB) September 17, 2019 Tucker, a Labrador retriever, was just a puppy when he began to show symptoms of osteoarthritis. At only four...
Latest News

Resumen: Antikor Biopharma y Essex Bio-Technology forjan una alianza estratégica en el conjugado medicamento-fragmentos de anticuerpo (FDC) para el tratamiento del cáncer

Newsemia
STEVENAGE, Inglaterra–(BUSINESS WIRE)–La empresa de biotecnología Antikor Biopharma Ltd se complace en anunciar que ha firmado un acuerdo de inversión de hasta 3.100.000 dólares con...
Biology

Biopharma Leaders Unite to Share Real-Life Business Development Experiences at LeadingBiotech’s Boston BD Conference

Newsemia
BOSTON (PRWEB) July 25, 2019 LeadingBiotech , an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston...
Latest News

A Biopharma Company Transforms Patient Care and Drug Development Using Patient Journey Analytics | a Success Story by Quantzig

Newsemia
LONDON–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/Analytics?src=hash" target="_blank">#Analytics</a>–Quantzig has announced the completion of their latest patient journey analytics engagement for a leading biopharma client. Source link...
Latest News

Pierre Fabre and its partner Array BioPharma announce interim analysis results from the BEACON CRC Trial of encorafenib + binimetinib + cetuximab for the treatment of BRAFV600E-mutant metastatic colorectal cancer

Newsemia
CASTRES, France–(BUSINESS WIRE)–Pierre Fabre today announced interim analysis results from the Phase 3 BEACON CRC trial evaluating the combination of encorafenib, a BRAF inhibitor, binimetinib,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy